P PRIMESTOCKFINDER.COM

MDT Stock Medtronic plc

US · NYSE
$94.79 -0.65% Prices as of close 2026-10-26

Last in our picks 2026-10-26 — not in the current list; analysis below is from that screen

Improving margins, procedure recovery, and reasonable valuation offer turnaround potential.

Future value: $118.00 (+23.68%) · 6-12 months

Signal breakdown

  • ▸Margin improvement and procedure recovery support estimate upgrades.
  • ▸Above 50-day MA (+4.43%)
  • ▸Above 200-day MA — long-term uptrend
  • ▸~24% upside to price target

Is MDT a buy right now?

Trend: MDT is trading above the 50-day average (+3.66%), RSI 28 — oversold territory, with a 3-month return of +9.10%.

Valuation & quality: Medtronic plc trades on a trailing P/E of 23.3, forward P/E 14.8, PEG 1.71, price-to-book 2.42; fundamentals show net margin 13.9%, return on equity 10.6%, revenue growth 13.7% year on year.

Analyst consensus: 26 analysts have a mean 12-month price target of $104.62 (+10.4% vs the last close; range $85.00 – $121.00), consensus rating “buy”.

Income: trailing dividend yield 3.02%.

Our screen: STRONG BUY (score 4) — Improving margins, procedure recovery, and reasonable valuation offer turnaround potential.

Computed from end-of-day data; not personal advice.

12-month price chart

101.7 73.8 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-09 → 2026-10-26 (USD). Range 73.8 – 101.7.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-11.30%-6.60%-8.80%+6.00%+9.20%+6.20%-4.80%+9.90%

Fundamentals

Market cap
$121.25B
P/E (ttm)
23.3
Forward P/E
14.8
EPS (ttm)
$4.07
Price / book
2.42
PEG
1.71
Beta
0.57
Net margin
13.9%
ROE
10.6%
Revenue growth
13.7%
Earnings growth
40.7%
Revenue (ttm)
$37.54B
Free cash flow
$5.41B
Debt / equity
55%
Dividend yield
3.02%
52-wk range
$73.31 – $106.33
Volume
6,781,552
Avg volume (3m)
16,476,539

Analyst price target

Mean target
$104.62
Low
$85.00
High
$121.00
Analysts
26
Consensus
BUY

Technical signals

RSI (14)
28.0
vs 50-day MA
+3.66%
1-mo return
+6.94%
3-mo return
+9.10%
Volume z-score
-1.56

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.

Sector: Healthcare · Industry: Medical Devices · Ireland · 95,000 employees · Website

Related Health Care picks

BMRNBioMarin PharmaceuticaIONSIonis Pharmaceuticals,BSXBoston Scientific CorpSYKStryker CorporationUNHUnitedHealth Group IncHUMHumana Inc.BMYBristol-Myers Squibb CHNGEHinge Health, Inc.

Browse: all US stocks · Health Care picks · today's movers

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.